[Penbutolol and arterial hypertension].

Abstract

Penbutolol has proved particularly effective and suitable for the treatment, even on a long-term basis, of recently developed hypertension, especially in its hyperkinetic forms. The drug produces minimal side effects, is well tolerated and gives an early therapeutic response. In addition penbutolol does not cause any significant alterations in the biohumoral parameters of the patients treated and is ideal for combination with dihydralazine, reserpine and dihydrochlorotiazide in the treatment of more stubborn cases, making it possible to reduce the doses of the other drugs without causing bradycardia.

• Authors: A Torriani, M Bravi, M Broglia, G Giuffrè, V Carisdeo
• Journal: Minerva medica (Minerva Med) Vol. 78 Issue 18 Pg. 1375-80 (Sep 30 1987) ISSN: 0026-4806 [Print] Italy
• Vernacular Title: Penbutololo e ipertensione arteriosa.
• PMID: 3658210 (Publication Type: English Abstract, Journal Article)

Chemical References

• Propanolamines
• Hydrochlorothiazide
• Penbutolol
• Reserpine
• Dihydralazine

Topics

• Blood Pressure (drug effects)
• Diabetes Complications
• Dihydralazine (therapeutic use)
• Drug Therapy, Combination
• Female
• Humans
• Hydrochlorothiazide (therapeutic use)
• Hyperlipidemias (complications)
• Hypertension (complications, drug therapy)
• Hyperthyroidism (complications)
• Male
• Penbutolol (therapeutic use)
• Propanolamines (therapeutic use)
• Reserpine (therapeutic use)